Published in Vasc Health Risk Manag on January 01, 2008
Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND). Alzheimers Res Ther (2009) 1.00
Microparticles induce cell cycle arrest through redox-sensitive processes in endothelial cells: implications in vascular senescence. J Am Heart Assoc (2012) 0.96
Differential effects of age and history of hypertension on regional brain volumes and iron. Neuroimage (2010) 0.94
Prevalence, Correlates, and Prognosis of Healthy Vascular Aging in a Western Community-Dwelling Cohort: The Framingham Heart Study. Hypertension (2017) 0.76
Arterial stiffness and decline of renal function in a primary care population. Hypertens Res (2016) 0.75
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (2007) 51.70
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med (2005) 28.21
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care (1993) 17.66
Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J (2006) 17.53
Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A (2004) 12.89
Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation (1993) 11.57
Association between telomere length in blood and mortality in people aged 60 years or older. Lancet (2003) 10.56
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2006) 9.87
Obesity, cigarette smoking, and telomere length in women. Lancet (2005) 8.59
The effects of social status on biological aging as measured by white-blood-cell telomere length. Aging Cell (2006) 6.80
Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet (2007) 6.57
Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet (2006) 5.85
Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol (2006) 5.28
White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol (2003) 5.04
Chronic stress at work and the metabolic syndrome: prospective study. BMJ (2006) 4.44
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet (2006) 4.26
Telomere shortening in atherosclerosis. Lancet (2001) 3.65
Arterial aging: is it an immutable cardiovascular risk factor? Hypertension (2005) 3.55
Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. Lancet (2006) 3.43
Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ (1995) 3.37
Rise in insulin resistance is associated with escalated telomere attrition. Circulation (2005) 3.27
Health in an unequal world. Lancet (2006) 3.00
Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors. The Reykjavik Cohort Study. Eur Heart J (2002) 2.60
Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension (2004) 2.41
Incident coronary events and case fatality in relation to common carotid intima-media thickness. J Intern Med (2005) 1.94
Family burden of cardiovascular mortality: risk implications for offspring in a national register linkage study based upon the Malmö Preventive Project. J Intern Med (2004) 1.79
Hypertension causes premature aging of endothelial function in humans. Hypertension (1997) 1.70
Social factors and increase in mortality in Russia in the 1990s: prospective cohort study. BMJ (2003) 1.68
Telomere shortening of peripheral blood mononuclear cells in coronary disease patients with metabolic disorders. Intern Med (2003) 1.64
Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation (2001) 1.62
Incidence of stroke is related to carotid IMT even in the absence of plaque. Atherosclerosis (2004) 1.60
Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmö, Sweden. Diabet Med (2000) 1.58
Telomere shortening in human coronary artery diseases. Arterioscler Thromb Vasc Biol (2004) 1.57
Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res (2002) 1.46
Association of telomere shortening with impaired glucose tolerance and diabetic macroangiopathy. Atherosclerosis (2007) 1.40
Telomeres, sex, reactive oxygen species, and human cardiovascular aging. J Mol Med (Berl) (2002) 1.32
Intima media thickness as a surrogate marker for generalised atherosclerosis. Cardiovasc Drugs Ther (2002) 1.30
Psychosocial stress and cardiovascular disease: pathophysiological links. Behav Med (2002) 1.26
Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort). Diabet Med (2003) 1.26
Telomeres, telomerase, and human disease. N Engl J Med (2006) 1.23
Rationale, design, methods and baseline characteristics of the Asklepios Study. Eur J Cardiovasc Prev Rehabil (2007) 1.21
Occupational status, educational level, and the prevalence of carotid atherosclerosis in a general population sample of middle-aged Swedish men and women: results from the Malmö Diet and Cancer Study. Am J Epidemiol (2000) 1.19
Socioeconomic differences in the progression of carotid atherosclerosis in middle-aged men and women with subclinical atherosclerosis in Sweden. Soc Sci Med (2005) 1.18
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol. Diabetologia (2005) 1.09
Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia (2005) 1.05
Biological ageing: a fundamental, biological link between socio-economic status and health? Eur J Public Health (2004) 1.05
Telomere dysfunction in hypertension. J Hypertens (2007) 1.04
Plasma adiponectin levels in relation to carotid intima media thickness and markers of insulin resistance. Arterioscler Thromb Vasc Biol (2006) 1.03
Growth, telomere dynamics and successful and unsuccessful human aging. Mech Ageing Dev (2003) 1.02
Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study. J Intern Med (2007) 0.90
Assessment of inflammatory markers and endothelial function. Curr Opin Clin Nutr Metab Care (2006) 0.82
Differences in maternal and paternal transmission of coronary heart disease. Am J Prev Med (2006) 0.81
Apoptosis is involved in the senescence of endothelial cells induced by angiotensin II. Cell Biol Int (2007) 0.81
Premature ageing: the link between psychosocial risk factors and disease. Med Hypotheses (1996) 0.77
Adverse social factors predict early ageing in middle-aged men and women: the Ebeltoft Health Study, Denmark. Scand J Public Health (2003) 0.76